[Guillain-Barré syndrome secondary to Mycoplasma pneumoniae infection].
Villanueva
J Escota
JE
Marteles
M Sánchez
MS
Allué
R Montoiro
RM
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D020275:Guillain-Barre Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification*; D010956:Plasmapheresis; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D017291:Clarithromycin